Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1094 studies found for:    "Hepatitis B"
Show Display Options
Rank Status Study
21 Completed Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants
Condition: Hepatitis B
Interventions: Biological: Engerix™-B;   Biological: HBV-MPL vaccine (208129);   Biological: Hepatitis B vaccine, experimental formulation
22 Completed Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B
Condition: Hepatitis B
Interventions: Biological: MPL-Adjuvanted recombinant hepatitis B vaccine;   Biological: Engerix™-B
23 Active, not recruiting Study for Consolidation Period of Chronic Hepatitis B
Condition: Hepatitis B
Intervention:
24 Unknown  Hepatitis B Seroepidemiology Among Young Adults
Condition: Hepatitis B
Intervention:
25 Completed Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians
Condition: Hepatitis B
Intervention: Other: Data collection
26 Completed A Study of the Immune Response to Heplisav in Healthy Older Adults
Condition: Hepatitis B
Intervention: Biological: HEPLISAV
27 Completed
Has Results
Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine
Condition: Hepatitis B
Intervention: Biological: Engerix™-B
28 Not yet recruiting Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus
Condition: Hepatitis B
Intervention: Drug: Tenofovir Disoproxil Fumarate
29 Completed Hepatitis B Acceptability and Vaccination Incentive Trial
Condition: Hepatitis B
Intervention: Other: Incentive condition
30 Completed Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Condition: Hepatitis B
Intervention: Biological: Resiquimod gel
31 Unknown  A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults
Condition: Hepatitis B
Intervention: Biological: Hepatitis B vaccine
32 Completed Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine
Condition: Hepatitis B
Interventions: Biological: HBsAg formulated with different concentrations of MPL and Aluminium Salts;   Biological: Engerix™-B
33 Withdrawn Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation
Condition: Hepatitis B, Chronic
Intervention: Biological: Nabi-HB
34 Completed
Has Results
Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.
Condition: Hepatitis B Vaccine
Intervention: Biological: Engerix™-B Kinder
35 Completed Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders
Condition: Hepatitis B
Interventions: Biological: Recombinant MPL- adjuvanted hepatitis B vaccine;   Biological: Engerix™-B
36 Completed Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B
Condition: Hepatitis B
Interventions: Biological: Engerix™-B;   Biological: HBV-MPL 208129;   Biological: Vaccine containing HBsAg absorbed on aluminium salts - experimental formulation
37 Unknown  Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
Condition: Hepatitis B
Intervention:
38 Completed
Has Results
Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)
Condition: Hepatitis B Virus Infection
Interventions: Biological: Comparator: modified process hepatitis B vaccine;   Biological: Comparator: ENGERIX-B™
39 Active, not recruiting Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: NVR 3-778;   Drug: Placebo for NVR 3-778;   Drug: Pegasys
40 Terminated Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)
Condition: Hepatitis B
Interventions: Drug: Lamivudine;   Biological: Recombinant hepatitis B surface antigen

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.